Ocular Therapeutix, Inc. (OCUL) Financial Statements (2024 and earlier)

Company Profile

Business Address 15 CROSBY DRIVE
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments102,300164,164228,05754,43754,06241,538
Cash and cash equivalents102,300164,164228,05754,43754,06241,538
Restricted cash and investments      
Receivables21,32521,13512,2522,548201226
Inventory, net of allowances, customer advances and progress billings1,9741,2501,201954217122
Inventory1,9741,2501,201954217122
Deferred costs      108
Other undisclosed current assets4,0284,7514,6502,2311,7131,345
Total current assets:129,627191,300246,16060,17056,19343,339
Noncurrent Assets
Operating lease, right-of-use asset8,0424,8675,8446,655
Property, plant and equipment9,8566,9568,09510,15110,23610,478
Restricted cash and investments1,7641,7641,7641,7646,6141,614
Total noncurrent assets:19,66213,58715,70318,57016,85012,092
TOTAL ASSETS:149,289204,887261,86378,74073,04355,431
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29,22024,71317,01610,9039,1597,881
Accounts payable5,1234,5922,7093,2682,9653,571
Accrued liabilities24,09720,12114,3077,6356,1944,310
Deferred revenue576   
Debt   8,2901,126 5,545
Other undisclosed current liabilities1,5991,6241,358   
Total current liabilities:31,39526,33726,66412,0299,15913,426
Noncurrent Liabilities
Long-term debt and lease obligation54,00657,35948,79158,21724,78812,471
Long-term debt, excluding current maturities54,00651,43541,24349,31224,78812,471
Liabilities, other than long-term debt28,50933,192110,31312,1243,2213,387
Deferred revenue and credits3,2213,387
Deferred revenue13,38713,00012,000 
Other liabilities93     
Operating lease, liability8,6785,9247,5488,905
Derivative instruments and hedges, liabilities6,35120,19298,31312,124  
Total noncurrent liabilities:82,51590,551159,10470,34128,00915,858
Total liabilities:113,910116,888185,76882,37037,16829,284
Equity
Equity, attributable to parent35,37987,99976,095(3,630)35,87526,147
Common stock888543
Additional paid in capital652,213633,795615,338379,980333,114263,409
Accumulated deficit(616,842)(545,804)(539,251)(383,615)(297,243)(237,265)
Total equity:35,37987,99976,095(3,630)35,87526,147
TOTAL LIABILITIES AND EQUITY:149,289204,887261,86378,74073,04355,431

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues51,49443,52217,4034,2271,9901,923
Revenue, net1,923
Cost of revenue(4,540)(4,407)(2,083)(2,325)(465)(457)
Cost of goods and services sold(4,540)(4,406)(2,083)(2,325) (457)
Gross profit:46,95439,11515,3201,9021,5251,466
Operating expenses(125,608)(117,152)(78,167)(87,704)(60,643)(63,389)
Operating loss:(78,654)(78,037)(62,847)(85,802)(59,118)(61,923)
Nonoperating income (expense)7,61671,484(92,789)(570)(860)(1,463)
Investment income, nonoperating798331681,229879424
Interest and debt expense(7,022)(6,671)(6,768)(6,101)(1,739)(1,892)
Loss from continuing operations:(78,060)(13,224)(162,404)(92,473)(61,717)(65,278)
Loss before gain (loss) on sale of properties:(13,224)(162,404)(92,473)(61,717)(65,278)
Other undisclosed net income (loss)7,0226,6716,768178,8451,739 
Net income (loss):(71,038)(6,553)(155,636)86,372(59,978)(65,278)
Other undisclosed net income (loss) attributable to parent    (172,744) 1,892
Net loss available to common stockholders, basic:(71,038)(6,553)(155,636)(86,372)(59,978)(63,386)
Interest on convertible debt4,5964,409    
Dilutive securities, effect on basic earnings per share(13,841)(78,121)    
Other undisclosed net loss available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(80,283)(80,265)(155,636)(86,372)(59,978)(63,386)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(71,038)(6,553)(155,636)86,372(59,978)(65,278)
Comprehensive income (loss):(71,038)(6,553)(155,636)86,372(59,978)(65,278)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (172,744) 1,897
Comprehensive loss, net of tax, attributable to parent:(71,038)(6,553)(155,636)(86,372)(59,978)(63,381)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: